Summary
Dr. Dominic D'Agostino explains how cancer cells depend on glucose and why the ketogenic diet can be used as a metabolic therapy to starve tumors. He covers the science behind FDG PET scans revealing cancer's metabolic vulnerability, supplement strategies for cancer prevention, and how combining caloric restriction with ketosis may enhance the effectiveness of conventional cancer treatments.
Key Points
- FDG PET scans work by detecting cancer cells' elevated glucose uptake, directly demonstrating their metabolic dependence on sugar.
- Ketogenic diets starve cancer cells by restricting glucose while providing ketones that healthy cells can use but most cancer cells cannot.
- Combining caloric restriction with ketosis may enhance the effectiveness of conventional treatments like radiation and chemotherapy.
- Exogenous ketones can raise blood ketone levels without strict dietary adherence, offering a supplemental metabolic therapy approach.
- Dom D'Agostino's research uses press-pulse therapy -- sustained metabolic stress (keto) combined with acute interventions (drugs, hyperbaric oxygen).
- Cancer prevention strategies include minimizing chronic hyperinsulinemia through time-restricted eating and reducing refined carbohydrate intake.
Key Moments
The prescription ketogenic diet uses a glucose-ketone index between 1 and 3 for therapeutic cancer treatment
Dr. D'Agostino distinguishes between a casual internet ketogenic diet and a prescription-strength ketogenic diet, where the glucose-ketone index (glucose divided by ketones in millimolar) is maintained between 1 and 3 for maximal therapeutic effect against cancer.
"The ketogenic diet is kind of like the icing on the cake, and when we talk about a ketogenic diet that puts your glucose ketone index within the range of like one to three, then that is what I call a prescription ketogenic diet."
Hyperglycemia and hyperinsulinemia are associated with 2 to 4 fold higher cancer incidence
Dr. D'Agostino opens by highlighting the strong epidemiological link between elevated blood sugar and insulin levels and dramatically increased cancer risk, framing metabolic health as a key cancer prevention strategy.
"these are really important things that an oncologist is never going to tell the patient to do hyper-licemia and hyper-insulinemia is associated with much greater, sometimes 2 to 3 to 4-fold higher incidence of cancer."
Beta-hydroxybutyrate as a signaling molecule — more than just brain fuel
Dr. D'Agostino explains that beta-hydroxybutyrate is not just an efficient fuel that produces 20% more ATP per unit of oxygen, but also a powerful signaling molecule that reduces reactive oxygen species, boosts antioxidant capacity, and has favorable epigenetic effects through histone modification.
"So you have a fuel that is more bioenergetically favorable when it's metabolized, it produces less reactive oxygen species, and then it also functions in a way that can increase our antioxidant capacity."
Exercise is a critically underappreciated component of metabolic cancer therapy
Dr. D'Agostino emphasizes that exercise, from simple walking to resistance training, provides tremendous metabolic benefits for cancer patients and should be talked about more as an integral part of metabolic therapy alongside diet and supplementation.
"exercise has tremendous metabolic benefits, preserving muscle, but they exercise is also an important tool for psychiatric help too."
